Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 835

    1.

    Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.

    Thadani U, Maranda CR, Amsterdam E, Spaccavento L, Friedman RG, Chernoff R, Zellner S, Gorwit J, Hinderaker PH.

    Ann Intern Med. 1994 Mar 1;120(5):353-9.PMID: 8093132 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.

    Parker JO.

    Am J Cardiol. 1993 Oct 15;72(12):871-6.PMID: 8213541 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.

    Thadani U, Bittar N.

    Am J Cardiol. 1992 Aug 1;70(3):286-92.PMID: 1632390 [PubMed - indexed for MEDLINE]Related articles

    4.

    Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.

    Thadani U, Prasad R, Hamilton SF, Voyles W, Doyle R, Karpow S, Reder R, Teague SM.

    Am J Cardiol. 1987 Sep 1;60(7):477-82.PMID: 3630929 [PubMed - indexed for MEDLINE]Related articles

    5.

    Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.

    Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Schulman P, Stahl A, DiBianco R, et al.

    Circulation. 1991 Dec;84(6):2398-408.PMID: 1959195 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.

    Chrysant SG, Glasser SP, Bittar N, Shahidi FE, Danisa K, Ibrahim R, Watts LE, Garutti RJ, Ferraresi R, Casareto R.

    Am J Cardiol. 1993 Dec 1;72(17):1249-56.PMID: 8256699 [PubMed - indexed for MEDLINE]Related articles

    7.
    8.

    A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.

    Walker JM, Curry PV, Bailey AE, Steare SE.

    Int J Cardiol. 1996 Feb;53(2):117-26.PMID: 8682597 [PubMed - indexed for MEDLINE]Related articles

    10.
    11.

    Duration of effects of isradipine during twice daily therapy in angina pectoris.

    Thadani U, Chrysant S, Gorwit J, Giles T, Archer S, Iteld B, Singh S, Copen D, Wakeford C, Hobbs S.

    Cardiovasc Drugs Ther. 1994 Apr;8(2):199-210.PMID: 7918132 [PubMed - indexed for MEDLINE]Related articles

    12.

    Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.

    Chen YH, Ding PY, Wang SP.

    Zhonghua Yi Xue Za Zhi (Taipei). 1998 Oct;61(10):577-83.PMID: 9830234 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.

    Seabra-Gomes R, Aleixo AM, Adao M, Machado FP, Mendes M, Bruges G, Palos JL.

    Am J Cardiol. 1990 Jun 1;65(20):1308-12.PMID: 2188493 [PubMed - indexed for MEDLINE]Related articles

    14.

    Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.

    Gunasekara NS, Noble S.

    Drugs. 1999 Feb;57(2):261-77. Review.PMID: 10188765 [PubMed - indexed for MEDLINE]Related articles

    15.

    Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris.

    Kohli RS, Rodrigues EA, Kardash MM, Whittington JR, Raftery EB.

    Am J Cardiol. 1986 Oct 1;58(9):727-31.PMID: 3766413 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate]

    Kośmicki M, Szwed H, Kowalik I, Sadowski Z.

    Pol Merkur Lekarski. 2002 Jul;13(73):52-5. Polish. PMID: 12362508 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.

    Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG.

    Indian Heart J. 2002 Mar-Apr;54(2):170-5.PMID: 12086380 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

    Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA; Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators.

    JAMA. 2004 Jan 21;291(3):309-16.PMID: 14734593 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.

    Shimada K, Sunayama S, Nakazato K, Satoh H, Kusama Y, Kawakubo K, Daida H.

    Int Heart J. 2006 Sep;47(5):695-705.PMID: 17106140 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.

    Hennig L, Andresen D, Hennig A, Levenson B, Brüggemann T, Schröder R.

    J Clin Pharmacol. 1991 Jul;31(7):636-40.PMID: 1894759 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data